ABOUT US

Our Story

We’ve spent years laying the scientific and technological groundwork to be the experts on the adaptive immune system. With our partners, we’ve spearheaded the discovery and development of its vast applications across healthcare —and it’s just the beginning.

OUR VISION

We aim to improve people’s lives by translating the scale and precision of their adaptive immune systems into products to diagnose, treat, and monitor disease.

Adaptive Culture

Who we are

Pioneers

We are a company of clever and collaborative individuals with distinct talents and a singular vision for translating the wisdom of the adaptive immune system with precision and at scale.

Team players

We enable leaders across various disciplines—immunology, sequencing, computational biology, and software development—to converge every day to uncover more about the adaptive immune system.

Partners

We empower our partners in the academic and biopharmaceutical communities with our platform, products, services, and data. Together, we’re helping to advance the field of immune-driven medicine.

LEADERSHIP

Uniquely equipped to achieve our bold vision

Chad Robins

Chief Executive Officer & Co-founder

Harlan Robins, PhD

Head of Innovation
& Co-founder

Julie Rubinstein

President

Chad Cohen

Chief Financial Officer

Sean Nolan

Chief Technical Officer

Sharon Benzeno, PhD

Senior Vice President, Adaptive Research & Business Development

Nancy Hill

Senior Vice President, Operations

Charles Sang

Senior Vice President, Adaptive Diagnostics

Stacy Taylor

General Counsel

Lori Stewart

Vice President, People

Mike Pellini, MD

Board Member

Eric Dobmeier

Board Member

David Goel

Board Member

Arnold J. Levine

Board Member

Peter Neupert

Board Member

Andris Zoltners

Board Member

Chad Robins

Chief Executive Officer & Co-Founder

ADVISORS

ADVISORS

Jay Shendure, MD, PHD

Professor, Genome Sciences, University of Washington

Gerald T. Nepom, MD, PHD

Director, Benaroya Research Institute at Virginia Mason, Seattle; and Professor (Affiliate), Department of Immunology, University of Washington School of Medicine

Edus Houston Warren, MD, PHD

Associate Professor, University of Washington; and Associate Member, Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center

David Miklos, MD, PHD

Associate Professor (Blood and Marrow Transplantation), Stanford University Medical Center

HEMATOLOGY BOARD

Frederick R. Appelbaum, MD

Executive Vice President and Deputy Director, Fred Hutchinson Cancer Research Center

Marco Davila, MD, PHD

Associate Professor, University of South Florida; and Associate Member, Moffitt Cancer Center

Rafael Fonseca, MD, PHD

Site Director, Hematological Malignancies, and Getz Family Professor of Cancer Chair, Department of Medicine, Mayo Clinic Arizona; Distinguished Mayo Investigator

Paolo Ghia, MD, PHD

Associate Professor, San Raffaele University Scientific Coordinator of the Lymphoma Unit, Department of Oncology, and principal investigator in the Laboratory of Lymphoid Malignancies at the San Raffaele Scientific Institute; Chairman, Basic & Translational Committee of the European Research Initiative on CLL (ERIC) Member, The Advisory Board for the Scientific Programme Committee of the European Hematology Association (EHA)

Thomas S. Kupper, MD

Thomas B. Fitzpatrick Professor of Dermatology, Harvard Medical School, and Chairman of Dermatology, Dermatologist in Chief Brigham and Women’s Hospital Dana Farber Cancer Institute

Richard A. Larson, MD

Professor of Medicine, Section of Hematology/Oncology Director of the Hematologic Malignancies Clinical Research Program, and Chairman of The Leukemia Committee of The Cancer and Leukemia Group B, University of Chicago

Ching-Hon Pui, MD

Chair of the Department of Oncology at St. Jude

Jerry Radich, MD

Member of the Clinical Research Division at the Fred Hutchinson Cancer Research Center; Professor of Medicine at the University of Washington

Andrew D. Zelenetz, MD, PHD

Medical Director, Quality Informatics, Memorial Sloan-Kettering Cancer Center

IMMUNO-ONCOLOGY BOARD

Robert Anders, MD, PHD

Associate Professor, Pathology, Johns Hopkins University School of Medicine

Mac Cheever, MD

Director of Solid Tumor Research, Fred Hutchinson Cancer Research Center, and Professor of Medicine/Oncology, University of Washington

F. Stephen Hodi, MD

Director, Center of Immuno-Oncology; and Sharon Crowley Martin Chair (Melanoma) Dana Farber Cancer Institute, and Professor of Medicine, Harvard Medical School

Elizabeth Jaffee, MD

Co-Director of the Division of Immunology, and Co-leader of the Gastrointestinal Cancers Program in the Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and Associate Director for Translational Research at the Sidney Kimmel Cancer Center at Johns Hopkins

Hiroyoshi Nishikawa, MD, PHD

Director, Division of Cancer Immunology, National Cancer Center East Japan

Eric Pamer, MD

Chief of the Infectious Diseases Service at Memorial Sloan-Kettering Cancer Center

Stan Riddell, MD

Scientific Director, Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center; and Professor of Oncology, University of Washington School of Medicine

Ton Schumacher, PHD

Group Leader, The Netherlands Cancer Institute

Mario Sznol, MD

Professor of Medicine (Medical Oncology), and Clinical Research Program Leader, Melanoma Program, Yale Cancer Center; Co-Director, Yale SPORE in Skin Cancer

Pierre Van Der Bruggen, PHD

Member, Ludwig Institute for Cancer Research in Brussels

Jedd Wolchok, MD, PHD

Chief, Melanoma and Immunotherapeutics Service at Memorial Sloan Kettering Cancer Center; Associate Director, Ludwig Center for Cancer Immunotherapy at MSKCC

Cassian Yee, MD

Professor at the MD Anderson Cancer Center, University of Texas

back_to_top

Join the Adaptive newsletter

Get news from Adaptive Biotech in your inbox.


By submitting this form, you are consenting to receive marketing emails from: Adaptive Biotechnologies, 1551 Eastlake Avenue E., Suite 200, Seattle, WA, 98102. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact